• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷脂酰肌醇3激酶和丙酮酸脱氢酶激酶-1对蛋白激酶Cζ的调控

Regulation of protein kinase C zeta by PI 3-kinase and PDK-1.

作者信息

Chou M M, Hou W, Johnson J, Graham L K, Lee M H, Chen C S, Newton A C, Schaffhausen B S, Toker A

机构信息

University of Pennsylvania School of Medicine, Department of Cell and Developmental Biology, Philadelphia 19104, USA.

出版信息

Curr Biol. 1998 Sep 24;8(19):1069-77. doi: 10.1016/s0960-9822(98)70444-0.

DOI:10.1016/s0960-9822(98)70444-0
PMID:9768361
Abstract

BACKGROUND

Protein kinase C zeta (PKC zeta) is a member of the PKC family of enzymes and is involved in a wide range of physiological processes including mitogenesis, protein synthesis, cell survival and transcriptional regulation. PKC zeta has received considerable attention recently as a target of phosphoinositide 3-kinase (PI 3-kinase), although the mechanism of PKC zeta activation is, as yet, unknown. Recent reports have also shown that the phosphoinositide-dependent protein kinase-1 (PDK-1), which binds with high affinity to the PI 3-kinase lipid product phosphatidylinositol-3,4,5-trisphosphate (Ptdins-3,4,5-P3), phosphorylates and potently activates two other PI 3-kinase targets, the protein kinases Akt/PKB and p70S6K. We therefore investigated whether PDK-1 is the kinase that activates PKC zeta.

RESULTS

In vivo, PI 3-kinase is both necessary and sufficient to activate PKC zeta. PDK-1 phosphorylates and activates PKC zeta in vivo, and we have shown that this is due to phosphorylation of threonine 410 in the PKC zeta activation loop. In vitro, PDK-1 phosphorylates and activates PKC zeta in a Ptdins-3,4,5-P3-enhanced manner. PKC zeta and PDK-1 are associated in vivo, and membrane targeting of PKC zeta renders it constitutively active in cells.

CONCLUSIONS

Our results have identified PDK-1 as the kinase that phosphorylates and activates PKC zeta in the PI 3-kinase signaling pathway. This phosphorylation and activation of PKC zeta by PDK-1 is enhanced in the presence of Ptdins-3,4-5-P3. Consistent with the notion that PKCs are enzymes that are regulated at the plasma membrane, a membrane-targeted PKC zeta is constitutively active in the absence of agonist stimulation. The association between PKC zeta and PDK-1 reveals extensive cross-talk between enzymes in the PI 3-kinase signaling pathway.

摘要

背景

蛋白激酶Cζ(PKCζ)是蛋白激酶C家族的成员,参与多种生理过程,包括有丝分裂原生成、蛋白质合成、细胞存活和转录调控。PKCζ作为磷酸肌醇3激酶(PI 3激酶)的作用靶点,近来受到了广泛关注,但其激活机制尚不清楚。最近的报道还显示,磷酸肌醇依赖性蛋白激酶-1(PDK-1)与PI 3激酶的脂质产物磷脂酰肌醇-3,4,5-三磷酸(Ptdins-3,4,5-P3)具有高亲和力结合,可磷酸化并有效激活另外两个PI 3激酶作用靶点,即蛋白激酶Akt/PKB和p70S6K。因此,我们研究了PDK-1是否是激活PKCζ的激酶。

结果

在体内,PI 3激酶对于激活PKCζ既是必需的也是充分的。PDK-1在体内可磷酸化并激活PKCζ,我们已证明这是由于PKCζ激活环中的苏氨酸410发生磷酸化所致。在体外,PDK-1以Ptdins-3,4,5-P3增强的方式磷酸化并激活PKCζ。PKCζ与PDK-1在体内相关联,并且PKCζ定位于细胞膜使其在细胞中组成性激活。

结论

我们的结果已确定PDK-1是在PI 3激酶信号通路中磷酸化并激活PKCζ的激酶。在Ptdins-3,4,5-P3存在的情况下,PDK-1对PKCζ的这种磷酸化和激活作用增强。与PKC是在质膜上受到调控的酶这一观点一致,靶向细胞膜的PKCζ在没有激动剂刺激的情况下组成性激活。PKCζ与PDK-1之间的关联揭示了PI 3激酶信号通路中酶之间广泛的相互作用。

相似文献

1
Regulation of protein kinase C zeta by PI 3-kinase and PDK-1.磷脂酰肌醇3激酶和丙酮酸脱氢酶激酶-1对蛋白激酶Cζ的调控
Curr Biol. 1998 Sep 24;8(19):1069-77. doi: 10.1016/s0960-9822(98)70444-0.
2
Dependence of insulin-stimulated glucose transporter 4 translocation on 3-phosphoinositide-dependent protein kinase-1 and its target threonine-410 in the activation loop of protein kinase C-zeta.胰岛素刺激的葡萄糖转运蛋白4转位对3-磷酸肌醇依赖性蛋白激酶-1及其在蛋白激酶C-zeta激活环中的靶位点苏氨酸-410的依赖性。
Mol Endocrinol. 1999 Oct;13(10):1766-72. doi: 10.1210/mend.13.10.0364.
3
Insulin and PIP3 activate PKC-zeta by mechanisms that are both dependent and independent of phosphorylation of activation loop (T410) and autophosphorylation (T560) sites.胰岛素和磷脂酰肌醇-3,4,5-三磷酸(PIP3)通过依赖和不依赖激活环(T410)磷酸化及自身磷酸化(T560)位点的机制激活蛋白激酶C-ζ(PKC-ζ)。
Biochemistry. 2001 Jan 9;40(1):249-55. doi: 10.1021/bi0018234.
4
Membrane localization of 3-phosphoinositide-dependent protein kinase-1 stimulates activities of Akt and atypical protein kinase C but does not stimulate glucose transport and glycogen synthesis in 3T3-L1 adipocytes.3-磷酸肌醇依赖性蛋白激酶-1的膜定位可刺激Akt和非典型蛋白激酶C的活性,但不刺激3T3-L1脂肪细胞中的葡萄糖转运和糖原合成。
J Biol Chem. 2002 Oct 11;277(41):38863-9. doi: 10.1074/jbc.M203132200. Epub 2002 Jul 29.
5
The phosphoinositide-dependent kinase, PDK-1, phosphorylates conventional protein kinase C isozymes by a mechanism that is independent of phosphoinositide 3-kinase.磷酸肌醇依赖性激酶1(PDK-1)通过一种独立于磷酸肌醇3激酶的机制使传统蛋白激酶C同工酶发生磷酸化。
J Biol Chem. 2001 Nov 30;276(48):45289-97. doi: 10.1074/jbc.M107416200. Epub 2001 Sep 28.
6
3'-phosphoinositide-dependent kinase-1 (PDK-1) in PI 3-kinase signaling.PI 3激酶信号传导中的3'-磷酸肌醇依赖性激酶-1(PDK-1)
Front Biosci. 2002 Apr 1;7:d886-902. doi: 10.2741/storz.
7
Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1).磷酸肌醇依赖性激酶1(PDK-1)对传统蛋白激酶C同工酶的调节作用。
Curr Biol. 1998;8(25):1366-75. doi: 10.1016/s0960-9822(98)00017-7.
8
Loss of PTEN expression does not contribute to PDK-1 activity and PKC activation-loop phosphorylation in Jurkat leukaemic T cells.在Jurkat白血病T细胞中,PTEN表达缺失对PDK-1活性和PKC激活环磷酸化无影响。
Cell Signal. 2007 Dec;19(12):2444-57. doi: 10.1016/j.cellsig.2007.07.020. Epub 2007 Aug 3.
9
Translocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase B.PDK-1易位至质膜对于其激活蛋白激酶B至关重要。
Curr Biol. 1998 Jun 4;8(12):684-91. doi: 10.1016/s0960-9822(98)70274-x.
10
Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes.蛋白激酶C(PKC)-ζ参与而二酰基甘油敏感的蛋白激酶C不参与L6肌管中胰岛素刺激的葡萄糖转运的证据。
Endocrinology. 1997 Nov;138(11):4721-31. doi: 10.1210/endo.138.11.5473.

引用本文的文献

1
YAP/TEAD4/SP1-induced VISTA expression as a tumor cell-intrinsic mechanism of immunosuppression in colorectal cancer.YAP/TEAD4/SP1诱导的VISTA表达作为结直肠癌免疫抑制的肿瘤细胞内在机制。
Cell Death Differ. 2025 May;32(5):911-925. doi: 10.1038/s41418-025-01446-2. Epub 2025 Jan 28.
2
Determination of Site-Specific Phosphorylation Occupancy Using Targeted Mass Spectrometry Reveals the Regulation of Human Apical Bile Acid Transporter, ASBT.使用靶向质谱法测定位点特异性磷酸化占有率揭示了人类顶端胆汁酸转运体ASBT的调控机制。
ACS Omega. 2024 Aug 30;9(37):38477-38489. doi: 10.1021/acsomega.4c02999. eCollection 2024 Sep 17.
3
14-3-3 and Smad2/3 are crucial mediators of atypical-PKCs: Implications for neuroblastoma progression.
14-3-3蛋白和Smad2/3是非典型蛋白激酶C的关键介质:对神经母细胞瘤进展的影响。
Front Oncol. 2023 Jan 20;13:1051516. doi: 10.3389/fonc.2023.1051516. eCollection 2023.
4
Liver Regeneration and Immunity: A Tale to Tell.肝脏再生与免疫:一个值得讲述的故事。
Int J Mol Sci. 2023 Jan 7;24(2):1176. doi: 10.3390/ijms24021176.
5
PKC isoforms activate LRRK1 kinase by phosphorylating conserved residues (Ser1064, Ser1074 and Thr1075) within the CORB GTPase domain.PKC 同工型通过磷酸化 CORB GTP 酶结构域内的保守残基(Ser1064、Ser1074 和 Thr1075)来激活 LRRK1 激酶。
Biochem J. 2022 Sep 30;479(18):1941-1965. doi: 10.1042/BCJ20220308.
6
Restoration of atypical protein kinase C ζ function in autosomal dominant polycystic kidney disease ameliorates disease progression.常染色体显性多囊肾病中恢复非典型蛋白激酶 C ζ 的功能可改善疾病进展。
Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2121267119. doi: 10.1073/pnas.2121267119. Epub 2022 Jul 22.
7
The Roles of Par3, Par6, and aPKC Polarity Proteins in Normal Neurodevelopment and in Neurodegenerative and Neuropsychiatric Disorders.Par3、Par6 和 aPKC 极性蛋白在正常神经发育以及神经退行性和神经精神疾病中的作用。
J Neurosci. 2022 Jun 15;42(24):4774-4793. doi: 10.1523/JNEUROSCI.0059-22.2022.
8
Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?核糖体蛋白 S6:癌症治疗的潜在靶点?
Int J Mol Sci. 2021 Dec 21;23(1):48. doi: 10.3390/ijms23010048.
9
PI3K Promotes Basal Cell Carcinoma Growth Through Kinase-Induced p21 Degradation.磷脂酰肌醇-3激酶通过激酶诱导的p21降解促进基底细胞癌生长。
Front Oncol. 2021 Jun 29;11:668247. doi: 10.3389/fonc.2021.668247. eCollection 2021.
10
Putative role of natural products as Protein Kinase C modulator in different disease conditions.天然产物作为蛋白激酶 C 调节剂在不同疾病状况中的推测作用。
Daru. 2021 Dec;29(2):397-414. doi: 10.1007/s40199-021-00401-z. Epub 2021 Jul 3.